Skip to main content
. 2021 Aug 18;17(11):4144–4154. doi: 10.1080/21645515.2021.1953346

Figure 4.

Figure 4.

Median frequency of glycoprotein E-specific CD4 T cells expressing any combination of activation markers (adapted according-to-protocol cohort for cell-mediated immunity – RZV group only). M = month; RZV = adjuvanted recombinant zoster vaccine. Error bars depict interquartile ranges Adapted denotes that for each time point presented, the corresponding according-to-protocol cohort was used.